HBV DNA, Quantitative PCR (HBVQ) Hepatitis B virus (HBV) detection and quantification is based on the amplification of a specific conservative DNA sequence and on measuring the amplification product concentration in the course of the PCR process by means of fluorescence marked probe.
HPV Genotyping + Pap Test (SHPVG+) Amplification of HPV genotype specific DNA sequences by PCR and followed by Biochip technology is used to detect and identify the specific HPV genotype(s) in this test.The HPV DNA genotyping test method identifies the presence of any of the 28 common HPV genotypes in the specimen. The low-risk HPV types identification include HPV 66, 11, 40, 42, 43, 44, 54, 61, and 70; whereas the high-risk HPV types identification include HPV 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66 and 68, 69, 73 and 82. It covers approximately 97.3% of all HPV infection in the general population.
STD Combo 3 (Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitallum), Qualitative PCR (SCOM3) The test dectects Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium DNA by multiplex realtime PCR which targets and amplify the conservative DNA regions of respective pathogens and report with different coloured florescence signals at the same time
STD Combo2 (CT, NG), Qualitative PCR (SCO2N) The test dectects Neisseria gonorrhoeae, Chlamydia trachomatis DNA by multiplex realtime PCR which targets and amplify the conservative DNA regions of respective pathogens and report with different coloured florescence signals at the same time
The test dectects Neisseria gonorrhoeae, Chlamydia trachomatis DNA by multiplex realtime PCR which targets and amplify the conservative DNA regions of respective pathogens and report with different coloured florescence signals at the same time
STD Combo 9 (Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitallum, Trichomonas vaginalis, Ureaplasma urealyticum/parvum, Gardnerella vaginalis, HSV1/2), Qualitative PCR (SCOM9) The test detects Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis, Gardnerella vaginalis, Ureaplasma urealyticum/parvum and Herpes Simplex Virus 1/2 DNA by multiplex realtime PCR, which target and amplify the conservative DNA regions of respective pathogens and report with different coloured florescence signals at the same time.
SGU (HSV1, HSV2 & Treponema pallidum), Qualitative PCR (SGU) The test detects Herpes Simplex Virus 1 , Herpes Simplex Virus 2 and Treponema pallidum DNA by multiplex realtime PCR, which target and amplify the conservative DNA regions of respective pathogens and report with different coloured florescence signals at the same time.
Human Papilloma Virus (HPV) Genotyping Qualitative PCR + Biochip (SHPVG) Amplification of HPV genotype specific DNA sequences by PCR and followed by Biochip technology is used to detect and identify the specific HPV genotype(s) in this test.The HPV DNA genotyping test method identifies the presence of any of the 28 common HPV genotypes in the specimen. The low-risk HPV types identification include HPV 66, 11, 40, 42, 43, 44, 54, 61, and 70; whereas the high-risk HPV types identification include HPV 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66 and 68, 69, 73 and 82. It covers approximately 97.3% of all HPV infection in the general population.
Epstein-Barr Virus (EBV), Quantitative PCR (OEBV) Epstein-Barr virus (EBV) detection and quantification is based on the amplification of a specific conservative DNA sequence of EBV and on measuring the amplification product concentration in the course of the PCR process by means of fluorescence marked probe.
ThinPrep, Liquid-base (TPAP)
Small Biopsy (sbo)
Large Biopsy (lbo)
Formalin fixed paraffin embedded biopsy (SBO) Formalin fixed tissue processed into paraffin section, H&E staining and examined under microscope to give definitive diagnoses.
Search Result
